Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,884 | 452 | 99.8% |
| Education | $12.15 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $830.65 | 48 | $0 (2024) |
| Alkermes, Inc. | $748.11 | 27 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $711.46 | 53 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $704.80 | 37 | $0 (2024) |
| Lundbeck LLC | $681.81 | 32 | $0 (2024) |
| ABBVIE INC. | $679.63 | 57 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $500.32 | 33 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $485.67 | 29 | $0 (2024) |
| ITI, Inc. | $448.45 | 25 | $0 (2023) |
| Axsome Therapeutics, Inc. | $433.04 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,590 | 194 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($500.32) |
| 2023 | $3,687 | 219 | ITI, Inc. ($419.96) |
| 2022 | $272.98 | 20 | ABBVIE INC. ($191.48) |
| 2021 | $345.64 | 20 | AbbVie Inc. ($345.64) |
All Payment Transactions
453 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.03 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/19/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: ADHD | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $17.86 | General |
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: CNS | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.05 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: Neuropsychiatry | ||||||
| 12/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: ADHD | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $3.17 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $30.92 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: CNS | ||||||
| 11/12/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: ADHD | ||||||
| 11/11/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Neurology | ||||||
| 11/11/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Insomnia | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: PSYCHIATRY | ||||||
About Allyson Feist
Allyson Feist is a Psychiatric/Mental Health healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2019. The National Provider Identifier (NPI) number assigned to this provider is 1376192138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allyson Feist has received a total of $7,896 in payments from pharmaceutical and medical device companies, with $3,590 received in 2024. These payments were reported across 453 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($7,884).
Practice Information
- Specialty Psychiatric/Mental Health
- Location Dallas, TX
- Active Since 09/05/2019
- Last Updated 09/05/2019
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1376192138
Products in Payments
- CAPLYTA (Drug) $948.77
- INGREZZA (Drug) $704.80
- VRAYLAR (Drug) $679.63
- SPRAVATO (Drug) $635.91
- ARISTADA (Drug) $563.34
- REXULTI (Drug) $487.82
- Austedo XR (Drug) $408.03
- Sunosi (Drug) $312.52
- ABILIFY MAINTENA (Drug) $300.93
- NUEDEXTA (Drug) $218.71
- BRINTELLIX (Drug) $204.63
- Azstarys (Drug) $195.22
- LYBALVI (Drug) $184.77
- ABILIFY ASIMTUFII (Drug) $181.18
- Xelstrym (Drug) $176.30
- INVEGA SUSTENNA (Drug) $172.41
- Secuado (Drug) $170.67
- QUVIVIQ (Drug) $168.89
- JORNAY PM (Drug) $142.66
- APLENZIN (Drug) $139.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Dallas
Jillian Adams
Psychiatric/Mental Health — Payments: $10,160
Kimberly Thompson, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $6,979
Deborah Riney
Psychiatric/Mental Health — Payments: $6,637
Roland Tsopze, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $5,505
Anandkumar Panchal, Aprn, APRN
Psychiatric/Mental Health — Payments: $4,985
Mrs. Bolanle Olayiwole, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $4,653